Trombendarterectomia aorto-femoral by Aguiar, Eduardo Toledo de et al.
	
REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(4):147-160, 2002JULY-AUGUST
From the Vascular Surgery Service, Hospital
das Clínicas, Faculty of Medicine University
of São Paulo.
AORTOFEMORAL THROMBOENDARTERECTOMY
Eduardo Toledo de Aguiar, Alex Lederman, Cid José Sitrângulo Júnior and
Pedro Puech-Leão
RHCFAP/3087
AGUIAR ET et al. - Aortofemoral thromboendarterectomy. Rev. Hosp. Clín. Fac. Med. S. Paulo 57(4):147-160, 2002.
PURPOSE: To study whether endarterectomy is feasible in all patients with aortofemoral atherosclerotic obstruction,
considering early and late results.
METHODS: A clinical, prospective, and descriptive study carried out in a university hospital. Inclusion criteria were
atherosclerotic aortofemoral obstructive disease, clinical status compatible with major surgery, and absence of prior restorative
procedure. Exclusion criteria were aneurysm, inflammatory arterial disease, and prior restorative procedure found during
surgery. Eighty patients entered the protocol, but 9 were excluded (11.2%). Seventy-one patients, mean age of 57.3 years,
underwent endarterectomy. Operative indications were intermittent claudication and critical ischemia. A ring-stripper
endarterectomy technique was employed in all patients. Results were related to age, gender, symptoms, presence of diabetes
mellitus, extension of endarterectomy, and extent of obstructive disease. Chi square or Fisher exact tests were used when
appropriate, and the Wilkoxon (Gehan) test was used to compare survival curves.
RESULTS: Sixty-eight (100%) endarterectomies were patent at discharge. The mortality rate was 4.2%. The amputation
rate (4.3%) was higher in diabetic patients and when there was associated femoropopliteal obstruction. The 5-year survival
rate was 83.3%, and late deaths were mostly cardiovascular. Diabetes mellitus, age above 65 years, and associated
femoropopliteal obstruction lowered the survival rate. The 5-year patency rate was 87.0%. Critical ischemia and less
extensive endarterectomies were associated with a lower patency rate. There were no anastomotic aneurysms or deep
infections.
CONCLUSIONS: Aortofemoral thromboendarterectomy is feasible in 90% of patients, early mortality rate is low,
diabetic patients and those with associated femoropopliteal obstructive disease have a higher mortality rate, amputation
rate is low, late deaths are mostly cardiovascular, and late patency rate is high, and even higher in the intermittent claudication
group.
DESCRIPTORS: Aorta. Iliac artery. Endarterectomy. Atherosclerosis. Arterial reconstructive surgery.
INTRODUCTION
The first thromboendarterectomy
was performed by Dos Santos in 1947,
and after a few years, it was accepted
as a treatment for aortoiliac atheroscle-
rotic obstructions1-3. Technical diffi-
culties induced most surgeons to sub-
stitute prosthetic aortoiliac bypass, an
easier procedure, for endarterectomies.
During the 1950s, arterial prosthe-
sis development caused a great ad-
vance in vascular surgery4. These ar-
terial substitutes made aneurysm and
arterial occlusion surgical treatment
much easier and were employed indis-
criminately to correct all chronic ob-
structions, regardless of the artery in-
volved. Earlier results showed that
these synthetic arterial grafts were not
suitable for small caliber arteries, so
for these vessels the saphenous vein
became the ideal substitute. Dacron
grafts became the ideal substitute for
larger arteries and are widely used to
treat the Leriche syndrome.
Unfortunately, patients with an ar-
terial prosthesis are always at risk of
complications developing after the
graft implant. Anastomotic aneurysms
and graft infections may occur at any
time, and their surgical treatment is fol-
lowed by high mortality in cases of
graft infection5-9. Even with all the im-
provements in technology and surgi-
cal procedures, these complications
are not preventable.
Some surgeons still use endarterec-
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tomy techniques to treat arterial occlu-
sive disease. When reviewing the litera-
ture regarding the early and late com-
plications of this technique, one finds
instances of occlusion of the treated
segment, but instances of infection and
anastomotic aneurysms are not found.
In our service, thromboendarterec-
tomy is rarely used, and the treatment of
choice for aortoiliac occlusive disease is
the aortofemoral Dacron bypass10,11. Dur-
ing the past few decades, frequently oc-
curring graft infections that jeopardize
the prosthesis and the patient’s limb and
life induced us to use an autogenous
substitute and thus return to the use of
thromboendarterectomy.
The objective of this study is to
analyze whether thromboendarterec-
tomy is feasible in all aortoiliac-femo-
ral occlusions and whether early and
late results are comparable to results
from other techniques.
METHODS
This is a clinical prospective and
descriptive study. Inclusion criteria
were aortoiliac-femoral obstructions
due to atherosclerosis with or without
femoropopliteal occlusions, patient’s
clinical status allowing major vascu-
lar surgery, and absence of previous ar-
terial aortoiliac-femoral and femoro-
popliteal reconstruction. Exclusion
criteria were aneurysm diagnosed dur-
ing surgery, arterial inflammatory dis-
ease diagnosed during surgery, or pre-
vious arterial surgery not mentioned
prior to the operation and that was di-
agnosed during surgery.
Patients were randomly selected to
participate in the protocol from the
surgical ward of the university hospi-
tal. Patients who were admitted under
the author’s care and met inclusion cri-
teria were then included. All patients
had a preoperative angiography to
study the infrarenal abdominal aorta,
iliac arteries, and arteries of the lower
limbs to the feet.
Ring-stripper endarterectomy under
general anesthesia was performed on all
patients. The aorta and iliac and femo-
ral bifurcations were dissected. Dissec-
tion of the aorta’s left side, aortic bifur-
cation, and left common iliac artery
was avoided. A clamp was located at the
femoral bifurcation, and a transverse in-
cision was made 1 centimeter above the
clamp. The endarterectomy ring was in-
troduced until the iliac bifurcation was
reached. At this point, another arteri-
otomy of the common iliac artery was
made 1 centimeter above the bifurca-
tion, and the core was taken out. The
internal iliac artery was then exposed,
and any plaque that needed to be re-
moved was taken out with the help of
a Moynihan clamp. The ring was then
introduced through the common iliac
artery until it reached the aortic bifur-
cation. The same procedure was done
on the other side. Aortic endarterectomy
was completed with infrarenal cross-
clamping, longitudinal aortotomy, and
“open endarterectomy”. The common
iliac core was removed through
aortotomy. Closure of the aorta, iliac,
and femoral arteriotomies was done
sequentially, with clamp removal after
each suture (Fig. 1).
The following parameters were
Figure 1 - Aortofemoral thromboendarterectomy steps. A – Incisions. B – Beginning of endarterectomy at common femoral artery. C – Ring stripper
through common femoral artery. D – Atheroma plaques and thrombus. E – Longitudinal aortotomy and tranverse right iliac arteriotomy closed.
A B C D
E
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analyzed: early and late mortality,
early and late amputation rates, early
reoperations (during first 30-day pe-
riod), survival rate, late obstruction
rate (verified by femoral pulse loss and
duplex-scan), suture line aneurysms
(physical examination and duplex-
scan), deep surgical infection (verified
by the patient’s clinical status and spe-
cific cultures for agent isolation).
All patients were followed with du-
plex-scan at 3 months after surgery
and at least once a year after that.
The outcomes were then related to
age, gender, symptoms, presence of
diabetes mellitus, thromboendarterec-
tomy extension, and occlusive disease
extension into the aortoiliac-femoral
territory, associated or not with femoro-
popliteal obstructive disease.
Chi-square and Fisher’s Exact test
were applied with a significance of 5%.
Survival curves were built for late
death and late arterial occlusion. The
Wilcoxon (Gehan) test was applied
with a significance level of 5%.
All statistical analyses were made
using the SPSS for Windows program.
PATIENTS
Eighty patients were initially in-
cluded. Nine (11.2%) had to be ex-
cluded due to intraoperative findings
– 7 with abdominal aortic aneurysm,
1 with an aneurysm at the origin of the
external iliac artery, and 1 with a pre-
viously stented left common iliac ar-
tery (the stent did not show up on aor-
tography because of subtraction tech-
nique).
Seventy-one patients were in-
cluded. The mean age was 57.3 ± 9.9
years; 54 (76.1%) were male and 17
(23.9%) female. Twelve (16.9%) were
diabetic patients, 34 (47.9%) were hy-
pertensive patients, 70 (98.6%) were
smokers, 29 (40.8%) had critical limb
ischemia (rest pain with or without
ischemic lesions), 42 (59.2%) had in-
termittent claudication, 19 (26.8%) had
coronary artery disease, 12 (16.9%) had
carotid stenosis, and 32 (45.1%) had
femoropopliteal-associated occlusions.
The endarterectomy extension was
aorto-bifemoral (3 with associated
femoropopliteal restoration, 1 of which
bilateral) in 52 (73.2%) patients,
aortoiliac on one side and aortofemoral
on the other in 3 (4.2%), and iliac-
femoral (two bilateral and one with as-
sociated femoropopliteal bypass) in 9
(12.6%).
Aorto-bifemoral and aortoiliac on
one side and aortofemoral on the other
were classified in one group
(aortofemoral), and aortoiliac and iliac-
femoral endarterectomies in another.
RESULTS
At hospital discharge, 68 (100%)
patients had patent restorations (3 early
deaths excluded). The preoperative and
postoperative angiograms of a patient
with juxtarenal aortic occlusion in
which the disease extended throughout
the iliac arteries reaching the common
femoral arteries are shown in figure 2.
Thirteen (18.3%) patients had immedi-
ate occlusion. One patient died of meta-
bolic disorders, and the other 12 had a
successful redo operation.
Reoperations were due to superfi-
cial femoral artery flaps (5), deep femo-
ral artery occlusion caused by flaps (2),
thrombosis due to hypotension (2), in-
complete external iliac artery endarter-
ectomy (2), and incomplete common
iliac artery endarterectomy (1).
Three (4.5%) patients had to un-
dergo fasciotomy and developed neu-
rological sequelae that disappeared
within 6 months. One diabetic patient,
after reoperation, developed a wound
infection, calf abscess, and sepsis. De-
spite all complications, there was no
compromise of arterial restoration.
There was no statistically signifi-
cant association of reoperation rates
with age group, gender, presence of
diabetes, symptom type, endarterec-
tomy extension, and presence of asso-
ciated femoropopliteal occlusion.
Three amputations had to be done
(amputation rate of 4.2%): 2 at femoral
level and 1 transmetatarsal (caused by
atheroembolism on the contralateral
limb after iliac-femoral endarterectomy).
Acute small artery occlusion occurred
during ring endarterectomy of the left
common iliac artery to the aorta. The
pré pós pós
Figure 2 - Preoperative and postoperative angiography (aortofemoral thromboendarterectomy).

REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(4):147-160, 2002 JULY-AUGUST
other 2 amputations were due to exten-
sive gangrene after aortoiliac-femoral
thromboendarterectomy. Even with a
successful arterial restoration, the
ischemic lesion continued to develop
in one patient. The other patient devel-
oped gaseous gangrene after surgery.
Neither of these patients was diabetic.
There was no statistically signifi-
cant association of amputation rates
with age group, gender, presence of
diabetes, or endarterectomy extension.
A statistically significant association
of amputation with type of symptom
was found; amputations occurred only
after operations done for critical
ischemia.
Three patients died in the immedi-
ate postoperative period. All were male,
2 were older than 65 years of age, and
2 were diabetics. The mortality rate was
4.2%. The causes of death were me-
senteric thrombosis in a diabetic patient
and mio-nephrotic-metabolic syndrome
in 2 patients (one had an immediate
postoperative thromboendarterectomy
occlusion, and the other was a diabetic
with a bilateral femoropopliteal ob-
struction with a clamping time greater
than 2 hours due to technical difficul-
ties). Two of these patients had surgery
due to intermittent claudication, and
the third one was due to critical
ischemia. All 3 patients had aortoiliac-
femoral thromboendarterectomy. There
was no statistically significant associa-
tion of mortality rates with age, gender,
thromboendarterectomy extension, or
patient’s symptoms (Table 3). However,
patients with diabetes and with associ-
ated femoropopliteal occlusions had a
higher immediate death rate.
The life table shows a 5-year pat-
ency of 87.0% ± 5.6% (Fig. 3); late
reoperations were not included. Eight
occlusions occurred after endarterec-
tomy (through an inguinal incision
only): 4 aortoiliac-femoral, 3 aortoiliac,
1 ileo-femoral. Five patients underwent
reoperations successfully. Two years af-
ter primary surgery, the first patient de-
veloped occlusion of both common
femoral arteries to the origin of the deep
femoral artery where endarterectomy
was finished. Intimal hyperplasia was
observed at that point. Correction by
profundaplasty and thrombectomy was
successful. The second case had an ex-
ternal iliac artery endarterectomy 1 1/2
years after primary aortoiliac endarter-
ectomy. The third patient had an aortic
aneurysm occlusion after a bilateral
ileofemoral endarterectomy done
Table 2 - Immediate post-operative amputation rate by variables studied.
Amputation
Variable yes  no  Total Fisher exact
test
Age
<65 years 2 54 56
>65 years 1 14 15 0.51
Gender
Male 2 52 54
Female 1 16 17 0.56
Symptoms
Intermittent claudication 0 42 42
Critical ischemia 3 26 29 0.06
Diabetes mellitus
Yes 0 12 12
No 3 56 59 0.56
Endarterectomy
Aorto-bi-femoral 2 50 52
thromboendarterectomy
Aortoiliac or ileo-femoral 1 18 19 0.61
thromboendarterectomy
Fem-pop
Yes 2 30 32
No 1 38 39 0.42
Fem-pop: Femoropopliteal obstruction associated with aortoiliac-femoral obstruction.
Table 1 - Immediate reoperation rate by variables studied.
Immediate reoperation Qui square or
Variable yes no Total Fisher exact
test
Age
<65 years 11 45 56
>65 years   2 13 15 0.15
Gender
Male   8 46 54
Female   5 12 17 0.44
Symptoms
Intermittent claudication   8 34 42
Critical ischemia   5 24 29 0.84
Diabetes mellitus
Yes   1 11 12
No   12 47 59 0.30
Endarterectomy
Aorto-bi-femoral   11 41 52
thromboendarterectomy
Aortoiliac or ileo-femoral 2 17 19 0.25
thromboendarterectomy
Fem-pop
Yes 7 25 32
No 6 33 39 0.48
Fem-pop: Femoropopliteal obstruction associated with aortoiliac-femoral obstruction.
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through inguinal incisions. Diagnosis
was done during reoperation 11 months
after first surgery, and an aortofemoral
“Dacron” bypass was performed. The
fourth patient developed a left common
iliac artery occlusion 5 years after pri-
mary surgery. During preoperative arte-
riography, a right common iliac artery
stenosis was diagnosed. Ring endarter-
ectomy was successful in treating the
left-side occlusion. A balloon angio-
plasty of the right-side stenosis was
complicated by arterial rupture, and a
Dacron tube was interposed. The fifth
patient also developed a left-side com-
mon iliac artery stenosis that was suc-
cessfully treated with balloon angio-
plasty that occluded at the 40th postop-
erative day. A new thromboendarte-
rectomy of this segment was successful.
A sixth patient refused to undergo redo
surgery 9 years after an aortoiliac-femo-
ral endarterectomy. Two other patients
are still under evaluation for possible
reoperations (one with previous
aortoiliac-femoral thromboendarte-
rectomy and the other with aortoiliac
thromboendarterectomy).
There was no statistically signifi-
cant association of late patency with
gender, presence of diabetes, age, or
femoropopliteal-associated disease.
A statistically significant differ-
ence was observed when endarterec-
tomy length was analyzed: 91.9% ±
5.5% of aortoiliac-femoral thrombo-
endarterectomies were patent after 5
years compared to 73.9% ± 13.8% of
others (Fig. 4).
There was a statistically significant
association of the patency rate with
the type of symptom (intermittent
claudication or critical limb ischemia).
A 5-year patency of 95.0% ± 4.8% was
observed for patients with intermittent
claudication, while patients with criti-
cal limb ischemia had a 73.7% ±
12.4% patency rate (Fig. 5).
Six patients died during follow up.
Causes of death were acute myocardial
infarction (3), ischemic cerebrovascu-
lar accident (1), leukemia (1), and in-
testinal perforation during gyne-
cologic surgery (1). The life table
shows the 5-year survival rate of
85.3% ± 5.8% (Fig. 6).
There was no statistically signifi-
cant difference in the incidence of
mortality when patients were grouped
according to gender, endarterectomy
length, or symptom type (intermittent
claudication or critical ischemia).
Statistically significant differences in
the 5-year survival rates were observed
when patients were grouped according
to presence of diabetes (71.5% ±14.1%
versus 88.2% ± 6.3% for non-diabetic
patients), age (77.7% ± 11.3% for >65
years old versus 87.9% ± 6.2% for <65
years old), and femoropopliteal-associ-
ated disease (78.2% ± 7.9% versus
93.3% ± 6.4% for patients without
femoropopliteal occlusions) (Figs. 7,8,9).
Table 3 - Immediate mortality by variables studied.
Variable Death Total Fisher exact
yes no test
Age
<65 years 1 55 56
>65 years 2 13 15 0.11
Gender
Male 3 51 17
Female 0 17 17 0.43
Symptoms
Intermitten Claudication 2 40 42
Critical Ischemia 1 28 29 0.63
Diabetes mellitus
Yes 2 10 12
No 1 58 59 0.07
Endarterectomy
Aorto-bi-femoral 3 49 52
thromboendarterectomy
Aortoiliac or ileo femoral 0 19 19 0.38
thromboendarterectomy
Fem-pop
Yes 3 29 32
No 0 39 39 0.08
Fem-pop: Femoropopliteal obstruction associated with aortoiliac-femoral obstruction.
Number of operations included in the peiod:
71 53 41 32 22 15 12 8 6 2 1
Number of occlusions in the period:
1 1 1 2 0 2 0 1 0 0
Figure 3 - Patency of thromboendarterectomy.
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Number of operations included in the peiod:
Aorto-femoral:
52 39 32 25 16 11 8 6 4 2 1
Other:
19 14 9 7 6 4 4 2 2
Number of occlusions:
Aorto-femoral:
0 0 1 1 0 2 0 1 0 0
Other:
1 1 0 1 0 0 0 0 0
p Wicoxon (Gehan) = 0.07
Figure 4 - Patency by length of thromboendarterectomy.
Number of operations included in the peiod:
Claudication:
42 32 25 22 17 12 9 6 4 1 1
Critical ischemia:
29 21 16 10 5 3 3 2 2 1
Number of occlusions:
Claudication:
0 0 0 1 0 2 0 1 0 0
Critical ischemia:
1 1 1 1 0 0 0 0 0 0
p Wicoxon (Gehan) = 0.06
Figure 5 - Patency of thromboendarterectomy by symptoms.
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Número de doentes no período:
< 65 anos:
56 45 35 29 20 14 13 8 7 2 1
> 65 anos:
15 9 7 5 3 1 1
Número de eventos:
< 65 anos:
1 2 0 0 1 0 0 0 1 0
> 65 anos:
3 0 0 0 0 0 1
p Wicoxon (Gehan) = 0.02
Figure 7 - Survival of the surgically treated population by age.
Number of patients included in the peiod:
71 54 42 34 23 15 14 8 7 2 1
Number of deaths:
4 2 0 0 1 0 1 0 1 0
Figure 6 - Survival of the surgically treated population.
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Number of patients included in the peiod:
Non-diabetic:
59 45 67 29 20 12 12 6 5
Diabetic:
12 9 5 5 3 3 2 2 2 2 1
Number of deaths:
Non-diabetic:
2 1 0 0 1 0 1 0 1
Diabetic:
2 1 0 0 0 0 0 0 0 0
p Wicoxon (Gehan) = 0.03
Figure 8 - Survival of the surgically treated population by diabetes mellitus.
Number of patients included in the peiod:
Femoro-popliteal disease absent:
39 31 25 22 18 11 10 5 4
Femoro-popliteal disease present:
32 23 17 12 5 4 4 3 3 2 1
Number of deaths:
Femoro-popliteal disease absent:
0 0 0 0 1 0 1 0 1
Femoro-popliteal disease present:
4 2 0 0 0 0 0 0 0
p Wicoxon (Gehan) = 0.08
Figure 9 - Survival of the surgically treated population by femoropopliteal associated to
aortoiliac-femoral disease.
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DISCUSSION
This study was initially designed
to prove that endarterectomy is feasi-
ble for all atherosclerotic aortoiliac-
femoral obstructions. Therefore, it is a
prospective study that respects all in-
clusion and exclusion criteria. There
are a few prospective studies in the lit-
erature12-15. All patients complaining of
Leriche´s syndrome who were admit-
ted under the author’s care were pre-
pared for ring-stripper thrombo-
endarterectomy; patient selection ex-
clusively on arteriography was not
done. Of the 80 patients included,
there were 9 excluded because of di-
agnosis of intraoperative aneurysm and
the finding of a common iliac artery
stent during surgery. The stent was not
visualized on arteriography because of
technicalities of the digital subtraction
techniques. One important fact became
very clear: thromboendarterectomy
was not feasible in 10% of patients
with Leriche´s syndrome. Some authors
had mentioned this fact before and at-
tributed this to technical difficulties
such as calcified atheroma plaques and
not to aneurysms or previous proce-
dures16-18.
Our study population of 71 pa-
tients is smaller than other study
populations reported in the literature,
but it is similar in age, gender distri-
bution, associated risk factors, cardio-
pathy, and distal occlusive disease.
These similarities allow comparative
studies of our results and those in the
literature14,17,19-21.
The surgical technique employed
deserves special attention. A trans-
peritoneal access was used because we
had significant previous experience
with this approach. However, retroperi-
toneal access to the abdominal aorta
has recently become accepted in our
department and is now routinely em-
ployed; this was not the case at the be-
ginning of this study22,23.
Wylie´s (1952) ring endarterec-
tomy technique was employed.3 Distal-
to-proximal artery endarterectomy di-
minishes aortic cross-clamping time,
and a transverse arteriotomy at the ar-
terial bifurcation makes it easier to su-
ture, resulting in lower stenosis rates
and no need for patches. Longitudinal
arteriotomies frequently need patch-
ing14,17,19,20.
At hospital dismissal time, all
thromboendarterectomies were patent,
even if reoperation was needed. The
immediate reoperation rate was high.
According to Gaspard et al. (1972)
there are 4 factors that should be con-
sidered before starting an endarterec-
tomy: 1) artery diameter (the smaller
the arterial lumen the more difficult it
is), 2) kinking of the artery, 3) calcifi-
cations, and 4) “almost normal” arter-
ies, which are more difficult to endarte-
rectomize (especially when the com-
mon femoral and common iliac arter-
ies are compromised and external iliac
artery is spared)10. Recent data shows
a reoperation rate of 1.2% even in
more extensive thromboendarte-
rectomy14,19,24,25. As already described,
as surgeons become more experienced,
mortality and reoperation rate dimin-
ishes26.
These are reasons why most sur-
geons opt for endarterectomy only
when lesions are limited to aorta and
common iliac arteries27-33. According to
Brewster and Darling (1978), limited
obstruction occurs in 10% of patients
with aortoiliac occlusion, and these are
the cases in which endarterectomy
should be indicated because it is an
autogenous repair, a great advantage
over a prosthetic graft34.
According to results presented
here, there is no influence of the stud-
ied variables on the reoperation rate.
Technical difficulties such as cores left
within the arteries or flaps left at the
origin of the superficial femoral artery
occurred at the beginning of the study.
There were 3 immediate amputa-
tions despite patent restorations. In the
literature, there are citations of cases
in which amputations were necessary
after endarterectomy or aortofemoral
bypass surgery for intermittent claudi-
cation, and all amputations were due
to postoperative occlusion of the re-
stored arterial segment (graft or endar-
terectomy)35-37.
However, amputation does not nec-
essarily occur only after occlusion of
the arterial repair. Gaspard et al. (1972)
reports 3 diabetic patients that
evolved to amputation with normal
postoperative femoral pulse12. Barret et
al. (1985) observed the same in 2 of
424 aortofemoral restorations38.
Most postoperative amputation oc-
curs in patients with critical
ischemia30,39,40. Immediate postoperative
amputation rate is low, varying from
zero to 6.3% after surgery on aortoiliac-
femoral territory obstruction20,28,30,35,39.
This study’s amputation rate falls into
the accepted range. None of the ampu-
tations were due to endarterectomy fail-
ure. Two patients underwent amputa-
tion: one due to progression of gan-
grene and the other due to infection.
The third amputation case was a
transmetatarsal amputation on the con-
tralateral side due to atheroembolism.
This last case illustrates a major com-
plication of this technique. This study
reveals a high amputation risk for pa-
tients complaining of critical ischemia.
The mortality rate was 4.2% in this
study. The mortality rate cited in the lit-
erature varies from 1.1% to
6.9%13,14,19,25,36. It is very important to
emphasize that this statistic is related
only to ring-stripper endarterectomy,
since the usual technique employed to
treat aortoiliac-femoral occlusions is syn-
thetic bypass. The reported mortality rate
following aortobifemoral bypass surgery
ranges from 2% to 5%28, 33,37,41-43.
Initially, there were technical diffi-
culties that included determination of
the ideal surgical access and endarter-
ectomy extension. Older studies report
the same technical difficulties and also
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report a decrease in complication and
mortality rates as the surgeon’s experi-
ence increases20,44,45. Immediate death
analysis reveals that all 3 patients had
associated femoropopliteal occlusion,
and 2 were diabetic. All 3 had an
aortoiliac-femoral thromboendarte-
rectomy. Statistical analysis revealed a
significant difference when diabetes
and femoropopliteal occlusions were
analyzed. This means that when
present, these variables increase imme-
diate postoperative mortality risk. Ac-
cording to Brewster (1991),
multisegment disease usually occurs in
older patients—mostly males, who are
diabetics with coronary and cerebral
and visceral artery involvement/occlu-
sions27. Other authors report an increase
in mortality associated with age, female
gender, femoropopliteal disease — es-
pecially when there is critical ischemia
— and associated with the extent of the
endarterectomy14,28.
Mesenteric thrombosis was the
cause of death of a diabetic patient
with associated femoropopliteal occlu-
sion. Deaths in the other cases were as-
sociated with technical difficulties
during aortoiliac-femoral thrombo-
endarterectomy. These data support an
extensive preoperative patient evalu-
ation, especially if diabetes and distal
artery occlusions are present. No early
postoperative deaths occurred in the
aortoiliac and iliofemoral thrombo-
endarterectomy group. Similar results
have been reported by other sur-
geons35.
Late patency is an important fac-
tor to be analyzed in arterial repair.
Five years after initial thrombo-
endarterectomy, the patency rate was
87.3% ± 6.9% (late reoperations are
not included). All 6 cases of late oc-
clusions could be treated — 4 by
thromboendarterectomy and 2 by
Dacron bypass. Causes of occlusion
were intimal hyperplasia and progres-
sion of atherosclerotic disease distal to
prior thromboendarterectomy. Intimal
hyperplasia is a very important issue
still under study, especially in angio-
plasties, and cannot be avoided46-50
Published data shows a 5-year patency
rate of 64.9% to 91% for aortofemoral
repair9,24,28,33,37,38,51,52. Factors such as
age, gender, diabetes, type of repair
(thromboendarterectomy or bypass)
did not influence these results, but pa-
tient complaint was very important. In
our study, 91.3% ± 8.3% of
thromboendarterectomies associated
with intermittent claudication were
patent after 5 years versus only 81.3%
± 10.2% of thromboendarterectomies
associated with critical ischemia. These
results were statistically significant
and agree with those of other reported
studies14,27,28,43. These excellent results
support the use of surgical interven-
tion in patients with intermittent clau-
dication and good clinical status on
preoperative evaluations35,52,53.
Another important result is that
longer thromboendarterectomies have
longer patency times than shorter ones
do. Darling and Linton (1964) and
Wylie (1976) have already called atten-
tion to the fact that thrombo-
endarterectomy should be “complete”;
that is, all plaques should be removed,
and if necessary, thromboendarte-
rectomy should be extended to the first
branch of the deep femoral artery. This
theory supports the criteria used in our
service to always employ aortofemoral
bypass for aortoiliac occlusions, since
small lesions not bypassed may com-
promise the arterial repair after-
wards19,45,54. Reports in the literature
support that patients with limited le-
sions, especially aortoiliac, evolve with
good results on late evaluations26,38,44,45.
But the present article is highly sugges-
tive that late occlusions develop from
smaller atheroma plaques on distal ar-
teries that were not considered during
aortoiliac or iliac-femoral thrombo-
endarterectomy.
The survival rate of our study popu-
lation shows that 87.5% ± 4.5% of pa-
tients were still alive after 5 years. A
similar study for aortofemoral bypass
performed in our service had a 75.6%
survival rate after 5 years4. Neugebauer
and Heyn (1982) estimated that 78%
of patients who underwent surgery for
aortoiliac occlusions were alive after
5 years55. Szilagyi et al. (1986) esti-
mated that only 59% of patients were
alive after 5 years (same diagnoses and
treatment)33. The cause of death was
primarily cardiovascular, especially
acute myocardial infarc-
tion16,26,28,29,33,37,38,42,56.
There were no deaths related to late
complications of thromboendarte-
rectomy, in contrast to what occurs with
aortofemoral prosthetic bypass. Previ-
ous studies done in this hospital have
demonstrated that a high risk of devel-
oping infection and anastomotic aneu-
rysm exists when Dacron prostheses are
used, and that use of these devices is
associated with some deaths; the sec-
ond most frequent cause of late death
is complications related to the use of
prosthetic graft6,7,9,57,58. The same results
are reported from different vascular
centers59-64. Raptis et al. (1995) report a
1% per year postsurgical complication
rate associated with aortofemoral by-
pass for up to 10 years after surgery65.
The 5-year survival rate of this study is
higher than previous survival rates of
the population we treated with aorto-
femoral bypass. It is also higher than
survival rate of most authors except for
Barret et al. (1985) who report an 89%,
5-year survival rate for patients with
aortofemoral Dacron bypass12. The
small number of patients studied here
and the better cardiologic follow-up to-
day than before certainly influenced
this result. Nevertheless, uncertainty
persists regarding whether late compli-
cations and reoperations associated
with using a prosthetic graft can be
avoided, which would result in dimin-
ished late mortality9.
When the survival rate is analyzed
according to gender, kind of operation,
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and patient complaint, no significant
statistical differences emerged. Some
authors report that women may not
evolve as well as men, especially
younger women in the premenopausal
period66. This observation becomes
more evident with repairs below the
inguinal ligament, but is not that evi-
dent when the aorta is involved67,68.
Crawford et al. (1981) reports a 949
patient series whose survival rate is
lower when critical ischemia, older
age, and diabetes are present28. The sta-
tistically significant differences found
in this study suggest that older age,
presence of diabetes, and associated
femoropopliteal occlusion are all fac-
tors contributing to a lower 5-year sur-
vival rate.
In conclusion, thromboendarterec-
tomy is feasible for 90% of aortoiliac-
femoral occlusions and should be kept
in the surgical arsenal, since it is au-
togenous and has no extension limits.
In the past few years, angioplasty has
increased its popularity, but it still is
not feasible for more extensive le-
sions, and stents are often needed, re-
sulting in the higher rates of compli-
cations that are associated with the use
of Dacron prosthetic grafts44,69,70.
We conclude that thromboendarte-
rectomy is an adequate technique to
treat 90% of aortoiliac-femoral athero-
sclerotic occlusions, early mortality
rate is similar to that of other aortoiliac
repairs, mortality is higher in patients
who have diabetes mellitus and
femoropopliteal-associated occlusion,
early amputation rate is low and fre-
quently associated with critical
ischemia, there is a high reoperation
rate, most late deaths are due to car-
diovascular causes, and it is a durable
restoration.
RESUMO RHCFAP/3087
AGUIAR ET e col. - Trombendarte-
rectomia aorto-femoral. Rev. Hosp.
Clín. Fac. Med. S. Paulo 57(4):
147-160, 2002.
OBJETIVO: Estudar a exeqüibi-
lidade da trombendarterectomia em to-
dos os portadores de obstrução
aortilíaco-femoral aterosclerótica, seus
resultados imediatos e tardios.
MÉTODO: Trabalho clínico, pros-
pectivo e descritivo feito em hospital
universitário. Os critérios de inclusão
foram: obstrução aortilíaco-femoral
aterosclerótica associada ou não a obs-
truções fêmoro-poplíteas, condições
clínicas para suportar cirurgia de gran-
de porte e ausência de restaurações ar-
teriais nos territórios aortofemoral e
fêmoro-poplíteo. Os critérios de exclu-
são foram: aneurismas, doença arterial
inflamatória e restauração arterial pré-
via reconhecidos apenas no ato cirúr-
gico. Foram incluídos 80 doentes.
Nove (11,2%) foram excluídos. Parti-
ciparam do estudo 71 doentes, 54 ho-
mens (76,1%) e 17 mulheres (23,9%),
com média de idades igual a 57,3+9,9
anos. As indicações cirúrgicas foram
claudicação intermitente e isquemia
crítica. A técnica da trombendar-
terectomia com anéis foi empregada em
todos doentes. Os resultados foram re-
lacionados: a idade, sexo, queixa, di-
abetes mellitus, extensão da trom-
bendarterectomia, extensão da doença
obstrutiva arterial. Para a análise esta-
tística foram empregados os testes de
Qui quadrado ou exato de Fisher quan-
do necessários e Wilkoxon (Gehan)
para comparação de curvas de sobre-
vivência.
RESULTADOS: Sessenta e oito
(100%) restaurações estavam pérvias.
A obstrução imediata ocorreu em 13
(18,3%) doentes e 12 foram reoperados
com sucesso. Não houve diferenças
significativas na distribuição das
reoperações em relação às variáveis es-
tudadas. Houve três amputações (4,2%)
no grupo de isquemia crítica. A mor-
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talidade foi 4,2% e aumentou signifi-
cativamente nos pacientes diabéticos
e nos que apresentaram obstruções
fêmoro-poplíteas associadas. Após cin-
co anos 87,0±5,6% das restaurações
estavam pérvias; isquemia crítica e
endarterectomias aorto-ilíacas ou
ilíaco-femorais estavam associadas à
durabilidade menor. Após cinco anos
85,3±5,8% dos doentes estavam vi-
vos; diabetes, idade acima de 65 anos
e obstruções fêmoro-poplíteas associ-
adas estavam relacionadas à diminui-
ção da sobrevida dos pacientes.
CONCLUSÕES: A trombendar-
terectomia pode ser aplicada em apro-
ximadamente 90% dos casos de obstru-
ções ateroscleróticas aortilíaco-
femorais, a mortalidade imediata é acei-
tável, a taxa de amputações maiores
imediatas é baixa, a taxa de reoperações
imediatas é mais alta, os óbitos tardios
são de causa cárdio-vascular na sua
maioria, a restauração é durável princi-
palmente quando indicada para trata-
mento da claudicação intermitente.
DESCRITORES: Aorta. Artéria
ilíaca. Endarterectomia. Ateros-
clerose. Restauração arterial.
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